Descriptive Analysis of Amiloride Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS): A Retrospective Pharmacovigilance Study

Documenti analoghi

• Descriptive Analysis of Alteplase Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS): A Retrospective Pharmacovigilance Study
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• Descriptive Analysis of Ranolazine Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• Descriptive Analysis of DALTEPARIN Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• DOFETILIDE Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)
• Labetalol: A Descriptive Analysis of Adverse Events Reported in the FDA Adverse Event Reporting System (FAERS)
  di: Nehad Jaser Ahmed
  Pubblicazione: (2026)